Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Amortizatization of Intangibles (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Amortizatization of Intangibles data on record, last reported at $15000.0 in Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles rose 25.0% year-over-year to $15000.0; the TTM value through Sep 2025 reached $2.1 million, down 63.66%, while the annual FY2024 figure was $2.1 million, 63.72% down from the prior year.
  • Amortizatization of Intangibles reached $15000.0 in Q3 2025 per UTMD's latest filing, up from $14000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $6.6 million in Q4 2021 and bottomed at -$3.3 million in Q3 2021.
  • Average Amortizatization of Intangibles over 5 years is $762947.4, with a median of $13000.0 recorded in 2022.
  • Peak YoY movement for Amortizatization of Intangibles: crashed 33130.0% in 2021, then surged 40278.57% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $6.6 million in 2021, then plummeted by 99.79% to $14000.0 in 2022, then soared by 40278.57% to $5.7 million in 2023, then tumbled by 64.14% to $2.0 million in 2024, then crashed by 99.26% to $15000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $15000.0 in Q3 2025, $14000.0 in Q2 2025, and $12000.0 in Q1 2025.